Goldberg, M R <br/><br/>
Rizatriptan, a novel 5-HT1B/1D agonist for migraine: single- and multiple-dose tolerability and pharmacokinetics in healthy subjects.  [electronic resource] 

 -  Journal of clinical pharmacology  Jan 2000 
 - 74-83 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0091-2700 
<br/><br/><label>Standard No.: </label>10.1177/00912700022008595  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Blood Pressure--drug effects<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Placebos<br/>Serotonin Receptor Agonists--administration & dosage<br/>Time Factors<br/>Triazoles--administration & dosage<br/>Tryptamines